OPOS provides products and services to enable physicians to manage populations receiving chronic opioid therapy.
OPOS provides opioid treatment to patients while maintaining regulatory compliance. Their services generate revenue by reducing administrative overhead, reducing prescribing risk, and reducing administrative overhead.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 26, 2021 | Grant | $247.55K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |